Tenet Healthcare Corporation
THC | NYSE
$260.97
-$1.02 (-0.39%)
At close: Sep 21, 2026, 4:00 PM ET
$260.97
$0 (0.00%)
After-hours:
Sep 21, 2026, 5:55 PM ET
Market Data
Market Cap $21.1B
Enterprise Value $32.09B
Beta 1.23
Average Volume 1.31M
Shares Outstanding (Diluted) 83.96M
Shares Change YoY -8.53%
Institutional Ownership 94.49%
Exchange NYSE
ISIN US88033G4073
Price Performance
Price Change 1M -6.4%
Price Change 3M 44.3%
Price Change 6M 30.5%
Price Change YTD 30.8%
Price Change 1Y 34.5%
Price Change 3Y 285.3%
Price Change 5Y 265.6%
1M CAGR (ann.) 2.1%
1Y CAGR (ann.) 42.8%
5Y CAGR (ann.) 29.2%
All-Time CAGR 11.9%
Valuation
PE Ratio 10.06
Forward PE 10.90
PEG Ratio 0.15
Forward PEG -15.65
PS Ratio 0.96
Forward PS 0.90
PB Ratio 4.51
P/FCF Ratio 6.95
P/Adj. FCF Ratio 7.16
P/OCF Ratio 5.43
EV/Sales 1.47
EV/EBIT 7.70
EV/EBITDA 6.34
EV/FCF 10.62
Earnings Yield 9.9%
FCF Yield 14.4%
Adj. FCF Yield 14.0%
Financial Health
Net Debt $11.08B
Total Debt $13.25B
Cash & Short-Term Investments $2.17B
Total Assets $30.68B
Current Ratio 1.41
Quick Ratio 1.35
Debt / Equity Ratio 2.84
Debt / EBITDA 2.62
Debt / FCF 4.38
OCF / Debt 0.30
Interest Coverage 4.47
Altman Z-Score 2.09
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 26.9%
Operating Profit Margin 16.8%
EBITDA Margin 23.2%
Net Profit Margin 10.3%
FCF Margin 13.9%
Adj. FCF Margin 13.5%
SBC / Revenue 0.4%
SBC Impact (per share) -2.9%
Returns
Return on Assets 7.3%
Return on Equity 50.6%
Return on Invested Capital 11.9%
Return on Capital Employed 14.6%
Return on Tangible Assets 12.5%
Historical Growth (CAGR)
Revenue CAGR 3Y 3.1%
Revenue CAGR 5Y 2.6%
Revenue CAGR 10Y 1.1%
EPS CAGR 3Y 78.6%
EPS CAGR 5Y 45.3%
EPS CAGR 10Y 40.0%
FCF CAGR 3Y 46.5%
FCF CAGR 5Y 18.0%
FCF CAGR 10Y 23.8%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 32
EPS Growth Next 3Y 3.2%
Revenue Growth Next 3Y 3.4%
Earnings Date Oct 26, 2026
EPS Estimate (next Q) $4.67
EPS Growth Est (next Q) 26.2%
Revenue Est (next Q) $5.49B
Revenue Growth Est (next Q) 3.8%
Fair Value Estimates
Graham Number $246.51
Graham Upside -5.5%
Lynch Fair Value $648.25
Lynch Upside 148.4%
Price Target $284.77
Price Target Upside 9.1%
Cash Flow
Operating Cash Flow $4.02B
Free Cash Flow $3.02B
Adj. Free Cash Flow $2.94B
FCF Per Share $36.19
OCF Per Share $48.07
OCF/S Ratio 18.4%
Income Statement
Revenue $21.81B
Gross Profit $5.86B
Operating Income $3.66B
EBITDA $5.06B
Net Income $2.24B
EPS (Diluted) $25.93
Revenue / Employee $246.46K
Profit / Employee $25.32K
Employees 88,500
Add to Watchlist
Select watchlists to add or remove THC